An RPM Business Augmented by R&D Respiri Limited (ASX:RSH, OTCQB:RSHUF) is a pioneering presence in the Remote Patient Monitoring (RPM) and MedTech sectors. The company uses its innovative respiratory technology with a disruptive business model as an RPM provider to offer the only RPM program for respiratory disorders. As a differentiated RPM provider, Respiri’s mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and, exclusively, respiratory disease. Respiri’s globally unique medical device and its Remote Patient Monitoring services empower healthcare organisations to take action from patient data when needed, not only when scheduled. Respiri is strategically positioned to revolutionise chronic disease management globally and is focused on the US market, where RPM services are reimbursed by Current Procedural Terminology (CPT) Code reimbursement.
View Top Employees from Respiri LimitedWebsite | http://respiri.co/au |
Ticker | RSH |
Revenue | $750000 |
Employees | 18 (17 on RocketReach) |
Founded | 2006 |
Address | 432 St Kilda Rd, Level 9, Melbourne, Victoria 3004, AU |
Phone | +61 1300 117 377 |
Fax | +61 3 9822 7735 |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Retail, Medical Equipment Manufacturing, Health Care, Other Healthcare Technology Systems, Health Diagnostics, Decision/Risk Analysis |
Competitors | Bacchus Vascular, Coherex Medical, Entegrion, Inc., NeoChord, Inc., Tracoe Medical GmbH |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Respiri Limited employee's phone or email?
The Respiri Limited annual revenue was $750000 in 2024.
Peter Hildebrandt is the COO of Respiri Limited.
17 people are employed at Respiri Limited.
Respiri Limited is based in Melbourne, Victoria.
The NAICS codes for Respiri Limited are [334, 33].
The SIC codes for Respiri Limited are [38, 384].